Risk of CV outcomes with IV iron vs. placebo
About half of patients with HF has ID, with specific prevalence estimates for ID in chronic #HF ranging between 47 and 68% depending on the definition used for ID
What are upcoming #RCT on iron deficiency in #HeartFailure ? https://t.co/u5fV3dZZJV